Swift Biosciences (Ann Arbor, MI) develops enabling technologies for genomics, translational, and clinical research. Our technologies expand the range of sample inputs to extend the applications of next-generation sequencing (NGS). We have developed unique intellectual property (IP) to enhance adapter ligation to both single and double-stranded DNA, improve multiplexed PCR for targeted sequencing, NEW! RNA kits and novel solutions like Normalase for NGS workflows. Swift technologies are platform agnostic and applicable across multiples NGS platforms.
Brands: Swift Normalase, Swift 2S Turbo, Accel-Amplicon Panels, Accel-NGS Library Prep Kits and NEW! Swift RNA